Bookmark

Add to MyYahoo RSS

Biotech News

Biotech news continually updated from thousands of sources around the net.

31 min ago | Reuters

Teva, Pfizer settle patent lawsuit over painkiller Celebrex

Teva Pharmaceutical Industries Ltd said it settled a patent litigation with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster pain medication, Celebrex, in December.

Comment?

Related Topix: Pfizer, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Celebrex, Celecoxib (generic), Pharmaceuticals, Health, Pain

4 hrs ago | KTVN Reno

FDA OKs Merck Tablet to Reduce Ragweed Allergies

U.S. regulators have again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen.

Comment?

Related Topix: Merck , Medicine, Healthcare Industry, Merck & Co., Whitehouse Station, NJ

6 hrs ago | Reuters

GSK, facing bribery claims, battles to build new sales model

Drugmaker GlaxoSmithKline - hit by bribery claims in five countries - is to employ hundreds more doctors as members of staff as it seeks to build a new sales model designed to eliminate sharp marketing practices.

Comment?

Related Topix: Medicine, GlaxoSmithKline, Marketing

10 hrs ago | WCAX-TV Burlington

NY-based co. closing Syracuse-area lab in July

An Albany-based pharmaceutical company that's part of a $250 million economic development project in Buffalo is shutting down its Syracuse-area research center, eliminating 45 jobs.

Comment?

Related Topix: Albany Molecular Research, Medicine, Healthcare Industry, Cedarburg, WI

15 hrs ago | Reuters

UPDATE 1-GSK says investigating claims of bribery in Jordan, Lebanon

GlaxoSmithKline, Britain's biggest drugmaker, said on Wednesday it was investigating allegations of bribery involving some of its staff in Jordan and Lebanon, following earlier claims of corruption in China, Poland and Iraq.

Comment?

Related Topix: GlaxoSmithKline, Marketing

19 hrs ago | Reuters

Galapagos, GSK successfully conclude phase 2a study of skin disease drug

Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC.

Comment?

Related Topix: GlaxoSmithKline

Wed Apr 16, 2014

TheCourier.com

Study: Diabetic heart attacks and strokes falling

In this Friday, March 1, 2013 file photo, Chan Lai Ly, right, has his mouth examined by Honghue Duong, a physician's assistant, as part of a regular check-up related to his diabetes at International Community Health Services in Seattle.

Comment?

Related Topix: Medicine, Diabetes, Health, Centers for Disease Control and Prevention, Healthcare Industry, Epidemic, Natural Disasters

Reuters

Vermont Senate passes mandatory GMO food-labeling law

The Vermont Senate passed a bill on Wednesday that would make the state the first in the United States to enact mandatory labeling of foods made with genetically modified crops.

Comment?

Related Topix: Agriculture, Science

ABC News

Smartphone Apps to Help Patients Take Their Meds

Several smartphone apps are available to help patients take their medications as prescribed.

Comment?

Related Topix: Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Nanaimo Daily News

GlaxoSmithKline says it is looking into new bribery allegations in Jordan and ...

The company said Wednesday that it started looking into the conduct of "a small number of individuals" in December.

Comment?

Related Topix: GlaxoSmithKline, Medicine, Healthcare Industry

Investor's Business Daily

Dr. Reddy's Announces the Launch of Eszopiclone Tablets C-IV

Dr. Reddy's Laboratories announced today that it has launched Eszopiclone Tablets 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTAA tablets C-IV in the US market on April 15, 2014, following the approval by the United States Food & Drug Administration .

Comment?

Related Topix: Dr Reddys Laboratories

MSN Money

Stock futures tick up after earnings, prices data due

Stock index futures edged up on Tuesday after earnings from Coca Cola and Johnson & Johnson and ahead of economic data including inflation and manufacturing.

Comment?

Related Topix: Beverages, CocaCola, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Terrorism

Tue Apr 15, 2014

The Beaumont Enterprise

Asia shares rise, shrug off slower China growth

World markets turned lower on Tuesday amid concerns about instability in Ukraine, the value of technology stocks and an economic slowdown in China.

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

1 spot in the Tampa Bay Times' Top Workplaces list for 2014. It is the third time in five years for ASI to earn the a... )--The recently discovered fracture at the Wanapum Dam's spillway structure does not currently impact bond ratings for the project's owner, the Public Utility District No.

Comment?

Related Topix: Medicine, Gilead Sciences, Healthcare Industry, Semiconductors, Diodes, Electronics, Nuevo, CA

The Beaumont Enterprise

US stocks turn higher in choppy trading

Major U.S. stock indexes are turning higher in the late afternoon as the market shuffles between gains and losses.

Comment?

Related Topix: Financial Markets, Beverages, Coca-Cola Bottling Co., Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

Star-Telegram.com

Scientists find new sponge species off La Jolla

Scientists using a remote-controlled robot submersible have discovered a new species of poisonous sponge in deep waters off San Diego.

Comment?

Related Topix: San Diego, CA, La Jolla (San Diego, CA), La Jolla Pharmaceutical, Medicine, Healthcare Industry, Science / Technology, Robots

National Public Radio

US Stocks Drift Lower At Midday; Homebuilders Sink

Beazer Homes, Ryland Group and other homebuilder stocks fell after a survey showed that the industry's confidence in the housing market remains low.

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

WTAE-TV Pittsburgh

Stocks: Earnings to the rescue

Once you're logged in, at the top of each article, video or slideshow you will see a list of your Facebook friends who recently visited Choose to share stories you'e read with your friends or turn sharing OFF to keep your reading experience anonymous .

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Norwalk Citizen News

J&J Q1 net up 8 percent on sales jump, lower costs

Johnson & Johnson says its first-quarter profit rose 8 percent, because of restrained costs and a big jump in prescription drug sales.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Aidsmap

Sofosbuvir/ledipasvir coformulation cures more than 90% of...

A coformulation of sofosbuvir and ledipasvir taken for as little as 8 weeks produced high sustained response rates across the board for participants in the phase 3 ION trials, including people with HCV genotype 1 starting treatment for the first time, prior non-responders and people with liver cirrhosis, according to findings presented last week at ... (more)

Comment?

Related Topix: Medicine, Gilead Sciences, Healthcare Industry, Food and Drug Administration, Hepatitis, Health

•••
•••
•••
•••

Biotech Jobs

•••
•••
•••
•••
•••